| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 07/14/2011 | US20110171315 Oral recombinant helicobacter pylori vaccine and preparing method thereof |
| 07/14/2011 | US20110171305 Dehydrated hydrogel inclusion complex of a bioactive agent with flowable drug delivery system |
| 07/14/2011 | US20110171292 Peptide compositions and methods of use |
| 07/14/2011 | US20110171291 Pathologically-activated therapeutics |
| 07/14/2011 | US20110171290 Inhibition of angiogenesis and tumor metastasis |
| 07/14/2011 | US20110171289 Combinations for the treatment of diseases involving cell proliferation, migration or apoptosis of myeloma cells, or angiogenesis |
| 07/14/2011 | US20110171267 Anti-fungal composition |
| 07/14/2011 | US20110171266 Malaria vaccine |
| 07/14/2011 | US20110171265 Composition Comprising Parasite Eggs and Methods for Isolation and Storage of Parasite Eggs |
| 07/14/2011 | US20110171264 Protein Formulation |
| 07/14/2011 | US20110171263 Compositions and methods of use of orf-1358 from beta-hemolytic streptococcal strains |
| 07/14/2011 | US20110171262 Parvoviral capsid with incorporated gly-ala repeat region |
| 07/14/2011 | US20110171261 Immunogenic composition |
| 07/14/2011 | US20110171260 Influenza dna vaccination and methods of use thereof |
| 07/14/2011 | US20110171259 Novel Compositions and Adjuvants |
| 07/14/2011 | US20110171258 Polyvalent, primary hiv-1 glycoprotein dna vaccines and vaccination methods |
| 07/14/2011 | US20110171257 Herpes simplex virus amplicon vectors derived from primary isolates |
| 07/14/2011 | US20110171256 Viral strains derived from the vaccinia virus lister vacv-107 and uses thereof |
| 07/14/2011 | US20110171255 Expression vector encoding alphavirus replicase and the use thereof as immunological adjuvant |
| 07/14/2011 | US20110171254 Cytokine-coated cells and methods of modulating an immune response to an antigen |
| 07/14/2011 | US20110171253 Novel astrovirus |
| 07/14/2011 | US20110171252 Streptococcus suis vaccines and diagnostic tests |
| 07/14/2011 | US20110171251 Piscirickettsia salmonis antigens and use thereof |
| 07/14/2011 | US20110171250 Synthetic Gene Construct Coding for an HIV1 GAG and Use Thereof for Obtaining Anti-HIV-1 Vaccines |
| 07/14/2011 | US20110171249 Chimeric chikungunya virus and uses thereof |
| 07/14/2011 | US20110171248 Synthetic virus-like particles conjugated to human papillomavirus capsid peptides for use as vaccines |
| 07/14/2011 | US20110171245 Recombinant antigen for diagnosis and prevention of murine typhus |
| 07/14/2011 | US20110171244 Recombinant protein carrying human papillomavirus epitopes inserted in an adenylate cyclase protein or fragment thereof therapeutic uses thereof |
| 07/14/2011 | US20110171243 Compounds for treating amyloidoses |
| 07/14/2011 | US20110171242 Ligand for herpes simplex virus entry mediator and methods of use |
| 07/14/2011 | US20110171241 Stabilized Formulations Containing Anti-Interleukin-6 (IL-6) Antibodies |
| 07/14/2011 | US20110171240 Use of ccr9, ccl25/teck, and integrin alpha4 in diagnosis and treatment of melanoma metastasis in the small intestine |
| 07/14/2011 | US20110171239 pH INDUCED SILK GELS AND USES THEREOF |
| 07/14/2011 | US20110171238 Novel stra6 polypeptides |
| 07/14/2011 | US20110171237 Phep, an amino acid permease of staphylococcus aureus |
| 07/14/2011 | US20110171236 Anthrax and small pox replikins and methods of use |
| 07/14/2011 | US20110171235 Therapeutic monoclonal antibodies that neutralize botulinum neurotoxins |
| 07/14/2011 | US20110171234 Vaccine |
| 07/14/2011 | US20110171233 Antibodies Against Human Cytomegalovirus (HCMV) |
| 07/14/2011 | US20110171232 Methods of treating autoimmune diseases caused by small intestinal bacterial overgrowth |
| 07/14/2011 | US20110171231 ANTI-PlGF ANTIBODIES AND METHODS USING SAME |
| 07/14/2011 | US20110171230 Method of Identifying Agents that Promote Axonal Development |
| 07/14/2011 | US20110171229 Monoclonal antibodies for cspg4 for the diagnosis and treatment of basal breast carcinoma |
| 07/14/2011 | US20110171228 Methods and Compositions Relating to the Regulation of Apoptosis by MUC1 and BH3-Containing Proapoptotic Proteins |
| 07/14/2011 | US20110171227 Methods and compositions for treatment of skin disorders |
| 07/14/2011 | US20110171226 Novel Subtype of Closteridium Botulinum Neurotoxin Type A and Uses Thereof |
| 07/14/2011 | US20110171225 Novel Plasmodium Falciparum Gene Encoding Signal Peptide Peptidase and Method of Using Inhibitors Thereof for Inhibiting Malarial Infection |
| 07/14/2011 | US20110171224 PsrP IS A PROTECTIVE ANTIGEN AGAINST PNEUMOCOCCAL INFECTION |
| 07/14/2011 | US20110171223 Anti-peptide antibodies that cross react with protective antigen of bacillus anthracis and uses thereof |
| 07/14/2011 | US20110171222 Anti-her3 antibodies and uses thereof |
| 07/14/2011 | US20110171221 Compositions and methods for the treatment of a neoplasia |
| 07/14/2011 | US20110171220 Pd-1 specific antibodies and uses thereof |
| 07/14/2011 | US20110171219 Treating cancer stem cells using targeted cargo proteins |
| 07/14/2011 | US20110171218 Compositions and methods for increasing serum half-life |
| 07/14/2011 | US20110171217 Stable liquid antibody formulation |
| 07/14/2011 | US20110171216 Monoclonal antibodies specific for pancreatic neoplasia cells |
| 07/14/2011 | US20110171215 Pd-1 specific antibodies and uses thereof |
| 07/14/2011 | US20110171214 Efficient well being assessment and improved treatment protocol |
| 07/14/2011 | US20110171213 Methods for treating pancreatic cancer |
| 07/14/2011 | US20110171212 Methods and compositions for preventing radiation-induced pneumonitis |
| 07/14/2011 | US20110171211 Heat shock protein gp96 vaccination and methods of using same |
| 07/14/2011 | US20110171210 Humanized monoclonal antibodies and methods of use |
| 07/14/2011 | US20110171209 Potentiation of Autoimmune and Inflammatory Disease Treatments by Immune Regulatory Oligonucleotide (IRO) Antagonists of TLR7 and TLR9 |
| 07/14/2011 | US20110171208 Cd37 immunotherapeutic and combination with bifunctional chemotherapeutic thereof |
| 07/14/2011 | US20110171207 Compositions and methods for treating inflammation and auto-immune diseases |
| 07/14/2011 | US20110171206 Antibody combinations and use of same for treating cancer |
| 07/14/2011 | US20110171205 Novel 15571, 2465, 14266, 2882, 52871, 8203 and 16852 molecules and uses therefor |
| 07/14/2011 | US20110171204 Antibodies to ntb-a |
| 07/14/2011 | US20110171203 Methods for treating neoplastic disease targeting o-linked n-acetylglucosamine modifications of cellular protein |
| 07/14/2011 | US20110171178 Compositions and methods of using proislet peptides and analogs thereof |
| 07/14/2011 | US20110171176 Complement antagonists and uses thereof |
| 07/14/2011 | US20110171173 Ifn-alpha/beta-independent mechanism of antiviral protection through a novel ligand-receptor pair: ifn- ligands engage a novel receptor ifn-rn (crf2-12) and il-10r2 (crf2-4) for signaling andinduction of biological activities |
| 07/14/2011 | US20110171172 Compounds for inhibiting ksp kinesin activity |
| 07/14/2011 | US20110171171 Bridged secondary amines and use thereof as iap bir domain binding compounds |
| 07/14/2011 | US20110171170 Cytotoxic t cell defined egfr peptide and an optimized derivative peptide |
| 07/14/2011 | US20110171169 Peptides for active anti-cytokine immunization |
| 07/14/2011 | US20110171140 Absorption of therapeutic agents across mucosal membranes or the skin |
| 07/14/2011 | US20110171128 Aprotinin polypeptides for transporting a compound across the blood-brain barrier |
| 07/14/2011 | US20110171127 Nucleic acid and corresponding protein entitled 162p1e6 useful in treatment and detection of cancer |
| 07/14/2011 | US20110171125 ANTI-FcRH5 ANTIBODIES AND IMMUNOCONJUGATES AND METHODS OF USE |
| 07/14/2011 | CA2836154A1 Chemical reagents for the activation of polysaccharides in the preparation of conjugate vaccines |
| 07/14/2011 | CA2836153A1 Chemical reagents for the activation of polysaccharides in the preparation of conjugate vaccines |
| 07/14/2011 | CA2836140A1 Chemical reagents for the activation of polysaccharides in the preparation of conjugate vaccines |
| 07/14/2011 | CA2790197A1 Stabilized formulations containing anti-interleukin-6 receptor (il-6r) antibodies |
| 07/14/2011 | CA2787054A1 Enhanced cytotoxicity of anti-cd74 and anti-hla-dr antibodies with interferon-gamma |
| 07/14/2011 | CA2786306A1 Methods and compositions for providing protective immunity in the elderly |
| 07/14/2011 | CA2786019A1 Plasma kallikrein binding proteins |
| 07/14/2011 | CA2785226A1 Photo-inactivated viruses and systems and methods of using the same |
| 07/14/2011 | CA2784970A1 Novel pneumovirus compositions and methods for using the same |
| 07/14/2011 | CA2783846A1 Antibody formulation |
| 07/13/2011 | EP2343374A1 Molecules of HDV nucleic acids, fragments and applications thereof |
| 07/13/2011 | EP2343372A1 Method for predicting pharmacological efficacy of anti-tnf antibody preparation on rheumatoid arthritis, and pharmacological efficacy prediction apparatus |
| 07/13/2011 | EP2343321A1 Human antibodies specific for carcinoma |
| 07/13/2011 | EP2343320A1 GITR binding molecules and uses therefor |
| 07/13/2011 | EP2343318A2 Antibodies binding to a C-terminal fragment of Apolipoprotein E |
| 07/13/2011 | EP2343316A1 Ligand binding site of RAGE and uses thereof |
| 07/13/2011 | EP2343315A2 Nucleic acid and corresponding protein named 158P1D7 useful in the treatment and detection of bladder and other cancers |
| 07/13/2011 | EP2343313A1 Polypeptides from non-typeable haemophilus influenzae |
| 07/13/2011 | EP2343308A2 Novel immunogenic compositions for the prevention and treatment of meningococcal disease |
| 07/13/2011 | EP2343086A2 Antibodies to CD40 |